Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
65.50    1.00 (1.55%)
Bid:
65.10
Ask:
65.50
Spread: 0.40 (0.614%)
Market Cap: $40.74b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Acquisition

17 Nov 2010 12:04

RNS Number : 3448W
Axis Bank Limited
17 November 2010
 

 

Meeting of the Board of Directors of Axis Bank Limited (the "Company")

held on November 17, 2010

 

We wish to inform you that at a meeting of the Board of Directors of the Company ("Board") held today, the Board has considered and unanimously approved the acquisition by Axis Securities and Sales Limited ("ASSL"), a wholly owned subsidiary of the Company, of the financial services business of Enam Securities Private Limited ("Enam"), comprising the businesses of investment banking, equity capital markets, debt capital markets, stock broking (retail and institutional) and initial public offering ("IPO") application financing and loans against shares for the purpose of share acquisitions, distribution of third party products (including broking and commission of mutual funds, equity IPOs, capital gain bonds, fixed deposits, RBI bonds) and other financial products, advisory services in relation to the aforesaid and research, conducted by ESPL directly and through its wholly owned subsidiaries in India and overseas, namely, Enam Securities Direct Pvt. Ltd., Enam International Ltd. (UAE), Enam Securities Europe Limited (UK), Enam Finance Pvt. Ltd. (collectively, the "Enam Financial Services Business") by the Company.

 

The Enam Financial Services Business is proposed to be transferred to ASSL by way of a demerger pursuant to a scheme of arrangement under Sections 391-394 and other applicable provisions of the Companies Act, 1956 between the Company, Enam and ASSL and their respective shareholders and creditors ("Scheme"), which scheme was tabled and approved by the Board at its meeting.

 

In consideration for the demerger, the Board of Directors of the Company has approved that the Company shall issue an aggregate of 1,37,82,600 equity shares of face value Rs. 10 (Rupees Ten Only) each credited as fully paid up in exchange for 24,18,000 equity shares of Rs. 10 (Rupees Ten Only) each fully paid up shares held by the shareholders of Enam ("Share Entitlement Ratio"). The Share Entitlement Ratio has been arrived at based on the valuation report prepared by Haribhakti & Co. and confirmed under a fairness opinion prepared by Macquarie Capital Advisers (India) Pvt. Ltd. submitted to the Board at its meeting.

 

The Scheme is subject to the receipt of necessary approvals under applicable law, including the approval of the shareholders and creditors of the Company, Enam and ASSL and the relevant High Courts and the Reserve Bank of India.

The Board also approved the execution of agreements relating to the Acquisition, including an Implementation Agreement between the Company, ASSL, Enam and the Enam Shareholders, which provides the terms and conditions for the transfer of the Financial Services Business and related matters and a Brand License Agreement licensing the right to use the "Enam" brand to the Company and its affiliates for an agreed period.

 

A joint press release from the parties in relation to the transaction is enclosed.

http://www.rns-pdf.londonstockexchange.com/rns/3448W_-2010-11-17.pdf

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFIFLILDLII
Date   Source Headline
12th May 202210:11 amRNSCredit Rating Action
29th Apr 20221:48 pmRNSOutcome of Board Meeting - April 29, 2022
28th Apr 20222:57 pmRNSDisclosure of Related Party Transactions
28th Apr 202212:51 pmRNSOutcome of Board Meeting held on April 28, 2022
25th Apr 20221:44 pmRNSEarnings call intimation
11th Apr 20223:54 pmRNSPostal Ballot Results
8th Apr 20225:12 pmRNSRATING ACTION BY CARE RATINGS LIMITED
8th Apr 20221:02 pmRNSINTIMATION FOR BOARD MEETING
7th Apr 20221:26 pmRNSRATING ACTION BY CRISIL RATINGS LIMITED
30th Mar 20221:04 pmRNSPurchase of Citibank’s India Consumer Business
29th Mar 202210:34 amRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
28th Mar 20222:23 pmRNSAmendments to Fair Disclosure Code
23rd Mar 20228:19 amRNSINVESTMENT IN OPEN NETWORK FOR DIGITAL COMMERCE
22nd Mar 20222:38 pmRNSGrant of Stock Options
9th Mar 202212:14 pmRNSNotice of Postal Ballot
7th Mar 20223:19 pmRNSResults of Postal Ballot
4th Feb 20227:00 amRNSNotice of postal ballot
25th Jan 20221:23 pmRNSRe-appointment of Chairman
24th Jan 202212:36 pmRNSFinancial Results for quarter - December 31, 2021
18th Jan 20222:23 pmRNSEarnings Call - Update on Financial Results
10th Jan 20221:00 pmRNSAppointment of Company Secretary
10th Jan 202212:58 pmRNSRe-appointment of Deputy Managing Director
29th Dec 20217:00 amRNSRE-DESIGNATION
22nd Dec 202111:28 amRNSAllotment of Securities
21st Dec 20217:00 amRNSReclassification of Promoter
20th Dec 20217:00 amRNSUpdates
20th Dec 20217:00 amRNSCessation of Director
16th Dec 202112:13 pmRNSBoard Meeting to consider Financial Results
15th Dec 20211:58 pmRNSRating Action By Crisil Ratings Limited
15th Dec 20211:46 pmRNSRating action by ICRA Limited
14th Dec 202112:57 pmRNSAppointment of Director
9th Dec 20211:16 pmRNSApproval of Grant of Stock Options
30th Nov 20211:04 pmRNSReclassification of Promoters
30th Nov 20217:00 amRNSFitch Ratings Action
29th Oct 20214:41 pmRNSSecond Price Monitoring Extn
29th Oct 20214:36 pmRNSPrice Monitoring Extension
27th Oct 20211:25 pmRNSRe-designation - Deputy Managing Director
26th Oct 20212:17 pmRNSRelated Party Disclosure
26th Oct 20211:54 pmRNSUnaudited Financial Results - 30.09.2021
21st Oct 20217:33 amRNSEarnings call - Financial Results of the Bank
14th Oct 20213:29 pmRNSRe-appointment of Managing Director & CEO
12th Oct 202112:52 pmRNSReclassification of Promoter
29th Sep 20211:46 pmRNSChange in Director(s)
15th Sep 202112:34 pmRNSReclassification of Promoter
8th Sep 20212:17 pmRNSNotes Allotment Intimation
7th Sep 20214:12 pmRNSRating Action by CARE Ratings
7th Sep 20213:50 pmRNSReclassification of Promoter
2nd Sep 20217:00 amRNSDisclosure - Reg. 30 of SEBI (LODR) Regulations
31st Aug 20216:27 pmRNSSchedule of Analyst / Investor Meeting
31st Aug 20217:00 amRNSSchedule of Analyst /Investor Meeting/Interactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.